Drug Research
European Medicines Agency recommends bimekizumab in two new indications
UCB, a global biopharmaceutical company, announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued positive opinions recommending granting marketing authorization for bimekizumab in the European Union (EU) for the...
Drug Research
FDA approves the manufacture of new microbiome-based therapeutic VOWSTTM at Recipharm site
Recipharm, a Global contract development and manufacturing organization (CDMO), has announced today that its subsidiary, GenIbet Biopharmaceuticals, has been approved by the US FDA as a manufacturing site of VOWST, a breakthrough orally administered fecal microbiota product for the...
News
CluePoints Supports Launch of RBQM Live 2023 as Premier Event Sponsor
CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management (RBQM) Software for clinical trials, has launched registration for RBQM Live 2023, the foremost virtual event known for shaping the future of RBQM.
This year, the free-to-attend...
News
A Simple Guide to Cataract Surgery & How to Prepare
When your optician or medical doctor informs you that you have the beginnings of the formation of a cataract, either in one eye or indeed both, it can sometimes come as a shock, especially if you currently have absolutely...
Drug Research
Critical Medicines Act Proposed By EU To Boost Drug Access
A group involving 19 European Union member countries is pushing for steps to lessen the bloc’s dependence when it comes to Chinese imports as far as pharmaceutical ingredients are concerned, according to a paper dated May 2.
This move comes...
Drug Research
EU Drug Regulation Proposal Sparks Pushback From Industry
The EU's drug regulations can get a major makeover soon. In a set of proposals, the European Commission looks to address numerous shortfalls troubling the $148 billion pharmaceutical industry. The proposed upgrades give out the most significant revisions across...
Drug Research
EU Proposes Drug Manufacturing Overhaul, Faces Pushback
The European Union on April 26 has released a draft of the probable and proposed revamp of its drug manufacturing laws. The changes have gone on to cause controversy among the manufacturers, with some even opining that they might...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read